BRUKER CORPORATION Payments for (Proceeds from) Investments
BRUKER CORPORATION (BRKR) reported Payments for (Proceeds from) Investments of $7.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2026-02-27
- BRUKER CORPORATION payments for (proceeds from) investments for the quarter ending 2024-12-31 was $2.30M, a 58.18% decline year-over-year.
- BRUKER CORPORATION payments for (proceeds from) investments for the quarter ending 2024-09-30 was $36.00M, a 260.00% increase year-over-year.
- BRUKER CORPORATION payments for (proceeds from) investments for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION payments for (proceeds from) investments for the quarter ending 2024-03-31 was $10.00M, a 21.95% increase year-over-year.
- BRUKER CORPORATION payments for (proceeds from) investments for fiscal 2025 was $7.20M, a 85.09% decline from fiscal 2024.
- BRUKER CORPORATION payments for (proceeds from) investments for fiscal 2024 was $48.30M, a 94.76% increase from fiscal 2023.
- BRUKER CORPORATION payments for (proceeds from) investments for fiscal 2023 was $24.80M, a 58.80% decline from fiscal 2022.
- BRUKER CORPORATION payments for (proceeds from) investments for fiscal 2022 was $60.20M, a 11940.00% increase from fiscal 2021.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 6 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $7.20M 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $38.30M derived: sum of 2 quarters · filed 2026-02-27 | $38.30M derived: sum of 3 quarters · filed 2026-02-27 | $48.30M 10-K · filed 2026-02-27 |
| 2024-09-30 | $36.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $36.00M derived: sum of 2 quarters · filed 2024-11-07 | $46.00M 10-Q · filed 2024-11-07 | $51.50M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $10.00M 10-Q · filed 2024-08-09 | $15.50M derived: sum of 3 quarters · filed 2026-02-27 | $25.50M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $10.00M 10-Q · filed 2024-05-10 | $15.50M derived: sum of 2 quarters · filed 2026-02-27 | $25.50M derived: sum of 3 quarters · filed 2026-02-27 | $26.60M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $15.50M derived: sum of 2 quarters · filed 2026-02-27 | $16.60M derived: sum of 3 quarters · filed 2026-02-27 | $24.80M 10-K · filed 2026-02-27 |
| 2023-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $11.10M derived: sum of 2 quarters · filed 2024-11-07 | $19.30M 10-Q · filed 2024-11-07 | $38.70M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $9.30M 10-Q · filed 2024-08-09 | $28.70M derived: sum of 3 quarters · filed 2025-03-03 | $31.40M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $8.20M 10-Q · filed 2024-05-10 | $27.60M derived: sum of 2 quarters · filed 2025-03-03 | $30.30M derived: sum of 3 quarters · filed 2025-03-03 | $56.40M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $19.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $22.10M derived: sum of 2 quarters · filed 2025-03-03 | $48.20M derived: sum of 3 quarters · filed 2025-03-03 | $60.20M 10-K · filed 2025-03-03 |
| 2022-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $28.80M derived: sum of 2 quarters · filed 2023-11-09 | $40.80M 10-Q · filed 2023-11-09 | $40.80M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $26.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $38.10M 10-Q · filed 2023-08-09 | $38.10M derived: sum of 3 quarters · filed 2024-02-29 | $38.60M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $12.00M 10-Q · filed 2023-05-10 | $12.00M derived: sum of 2 quarters · filed 2024-02-29 | $12.50M derived: sum of 3 quarters · filed 2024-02-29 | $12.50M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $500.00K derived: sum of 2 quarters · filed 2024-02-29 | $500.00K derived: sum of 3 quarters · filed 2024-02-29 | $500.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $500.00K derived: sum of 2 quarters · filed 2022-11-04 | $500.00K 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $0.00 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $1.20M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |